Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Winter Games
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Moderna shares fall

Digest more
Top News
Overview
 · 1d
F.D.A. Refuses to Review Moderna Flu Vaccine
The vaccine maker Moderna said on Tuesday that the Food and Drug Administration had notified the company that the agency would not review its mRNA flu vaccine, the latest sign of federal health policy...

Continue reading

 · 1d · on MSN
Moderna says FDA refuses to review its application for flu vaccine
 · 21h
Moderna shares fall as FDA declines to review new flu vaccine
 · 1d
FDA declines to review Moderna application for new flu vaccine
US regulators will not review Moderna’s request to license a new, potentially more effective flu shot – even though the US Food and Drug Administration (FDA) previously gave the green light to the pro...

Continue reading

 · 1d
Kennedy-era FDA changes vaccine review process, blocks Moderna application
 · 1d
FDA refuses to review Moderna's flu vaccine application
NBC Los Angeles
4y

Pfizer, Moderna, Johnson & Johnson: How Effective Are They and How Do They Compare?

Despite a U.S. factory mixup, more Johnson & Johnson doses are becoming available in the U.S., marking the only single-shot vaccine option. So how effective is it and how does it compare to the Pfizer and Moderna vaccines? Stream Los Angeles News for free ...
New York Post
5mon

Pfizer, Moderna shares plunge on report that Trump officials plan to link 25 child deaths to COVID vaccine

Shares in Pfizer and Moderna fell 3.9% and 7.4%, respectively, Friday after a report that the Trump administration plans to link the deaths of 25 children to COVID vaccines. Trump health officials plan to include the claim in a presentation next week to a ...
  • Privacy
  • Terms